| RS2147678827 |
JAK3
|
Health Risk |
Likely pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS2147678860 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS2147681264 |
JAK3
|
Health Risk |
Likely pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS2147681381 |
PRPS1
|
Health Risk |
Likely pathogenic |
Arts syndrome, Arts syndrome |
| RS2147681484 |
PRPS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147681619 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS2147682409 |
PRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth disease X-linked recessive 5 |
| RS2147683334 |
JAK3
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency disease, Severe combined immunodeficiency disease |
| RS2147684782 |
PRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Arts syndrome |
| RS2147684810 |
PRPS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147686036 |
JAK3
|
Health Risk |
Likely pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS2147686196 |
OGT
|
Health Risk |
Likely pathogenic |
— |
| RS2147687373 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS2147690107 |
BRWD3
|
Health Risk |
Pathogenic |
— |
| RS2147691056 |
DOCK6
|
Health Risk |
Likely pathogenic |
— |
| RS2147691124 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS2147692665 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS2147693460 |
BRWD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 93 |
| RS2147706381 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2147706405 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2147706541 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2147706580 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS2147712442 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS2147714706 |
PIGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, PIGA-related disorder |
| RS2147717286 |
PIGA
|
Health Risk |
Likely pathogenic |
Nonpapillary renal cell carcinoma, Paroxysmal nocturnal hemoglobinuria |
| RS2147722151 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147722166 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147722497 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147722687 |
LARGE1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy type B6, Muscular dystrophy-dystroglycanopathy type B6 |
| RS2147723740 |
PIGA
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with epilepsy and hemochromatosis, Neurodevelopmental disorder with epilepsy and hemochromatosis |
| RS2147723760 |
PIGA
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Multiple congenital anomalies-hypotonia-seizures syndrome 2 |
| RS2147723922 |
PIGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 2, Multiple congenital anomalies-hypotonia-seizures syndrome 2 |
| RS2147724073 |
PIGA
|
Health Risk |
Likely pathogenic |
Paroxysmal nocturnal hemoglobinuria 1, Paroxysmal nocturnal hemoglobinuria 1 |
| RS2147727146 |
GCNA
|
Health Risk |
Likely pathogenic |
Non-obstructive azoospermia, Spermatogenic failure |
| RS2147727488 |
PIGA
|
Health Risk |
Likely pathogenic |
— |
| RS2147728009 |
GCNA
|
Health Risk |
Pathogenic |
Spermatogenic failure, X-linked |
| RS2147729149 |
GCNA
|
Health Risk |
Pathogenic |
Non-obstructive azoospermia, Spermatogenic failure |
| RS2147732931 |
GCNA
|
Health Risk |
Pathogenic |
Azoospermia, Spermatogenic failure |
| RS2147733170 |
KANSL1
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2147734937 |
KIAA0930
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2147734941 |
KIAA0930
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2147734951 |
KIAA0930
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2147736023 |
CASK
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS2147738058 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-hypotonic facies syndrome, X-linked |
| RS2147739739 |
KANSL1
|
Health Risk |
Pathogenic |
— |
| RS2147741933 |
KANSL1
|
Health Risk |
Pathogenic |
— |
| RS2147744889 |
TEX11
|
Health Risk |
Pathogenic |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS2147746087 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147746137 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2147746303 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
COL4A5-related disorder, X-linked Alport syndrome |
| RS2147746317 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147746685 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147746687 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147746709 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147746826 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147747293 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, Nonpapillary renal cell carcinoma |
| RS2147747375 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147747509 |
IL2RG
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147747770 |
PHKA1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXd, Glycogen storage disease IXd |
| RS2147748109 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147748142 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147748189 |
IL2RG
|
Health Risk |
Likely pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147748344 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147748363 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147748812 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147749450 |
HADHA
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS2147749507 |
KANSL1
|
Health Risk |
Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2147749578 |
IL2RG
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147749701 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147750252 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147750291 |
IL2RG
|
Health Risk |
Likely pathogenic |
— |
| RS2147750311 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147750359 |
IL2RG
|
Health Risk |
Likely pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147750382 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147750927 |
IL2RG
|
Health Risk |
Likely pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147750934 |
IL2RG
|
Health Risk |
Pathogenic |
— |
| RS2147751090 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147751144 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147751146 |
IL2RG
|
Health Risk |
Likely pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147751760 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147751762 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147751859 |
IL2RG
|
Health Risk |
Likely pathogenic |
X-linked severe combined immunodeficiency, Combined immunodeficiency |
| RS2147751877 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147751892 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS2147752783 |
PLP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS2147753069 |
HADHA
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS2147753555 |
HADHA
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS2147753630 |
HADHA
|
Health Risk |
Pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS2147753741 |
HADHA
|
Health Risk |
Pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS2147753780 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147753910 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147753940 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147754958 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147754967 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, Nonpapillary renal cell carcinoma |
| RS2147755024 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2147755143 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2147755217 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147755986 |
BRWD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 93 |
| RS2147759174 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147759208 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |